These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 3130956
1. Evidence that noradrenergic activity does not mediate the inhibition of luteinizing hormone secretion caused by vasoactive intestinal peptide. Alexander MJ, Clifton DK, Matsumoto AM, Steiner RA. Brain Res; 1988 Apr 05; 445(2):247-53. PubMed ID: 3130956 [Abstract] [Full Text] [Related]
2. Vasoactive intestinal polypeptide effects a central inhibition of pulsatile luteinizing hormone secretion in ovariectomized rats. Alexander MJ, Clifton DK, Steiner RA. Endocrinology; 1985 Nov 05; 117(5):2134-9. PubMed ID: 3899617 [Abstract] [Full Text] [Related]
3. Effect of [4Cl-D-Phe6,Leu17]VIP on the inhibition of pulsatile LH release by VIP and related peptides in the ovariectomized rat. Weick RF, Stobie KM, Noh KA. Neuroendocrinology; 1992 Nov 05; 56(5):646-52. PubMed ID: 1488097 [Abstract] [Full Text] [Related]
4. Vasoactive intestinal peptide inhibits luteinizing hormone secretion: the inhibition is not mediated by dopamine. Stobie KM, Weick RF. Neuroendocrinology; 1989 Jun 05; 49(6):597-603. PubMed ID: 2671777 [Abstract] [Full Text] [Related]
5. Effects of lesions of the suprachiasmatic and paraventricular nuclei on the inhibition of pulsatile luteinizing hormone release by exogenous vasoactive intestinal peptide in the ovariectomized rat. Stobie KM, Weick RF. Neuroendocrinology; 1990 Jun 05; 51(6):649-57. PubMed ID: 2114001 [Abstract] [Full Text] [Related]
6. Neuropeptide-Y suppresses pulsatile secretion of luteinizing hormone in ovariectomized rats: possible site of action. McDonald JK, Lumpkin MD, DePaolo LV. Endocrinology; 1989 Jul 05; 125(1):186-91. PubMed ID: 2661205 [Abstract] [Full Text] [Related]
7. Corticotropin-releasing hormone mediates suppression of pulsatile luteinizing hormone secretion induced by activation of alpha-adrenergic receptors in the paraventricular nucleus in female rats. Tsukamura H, Nagatani S, Cagampang FR, Kawakami S, Maeda K. Endocrinology; 1994 Mar 05; 134(3):1460-6. PubMed ID: 8119187 [Abstract] [Full Text] [Related]
8. Concomitant inhibition of pulsatile luteinizing hormone (LH) and stimulation of prolactin release by prostacyclin (PGI2) in ovariectomized (OVX) conscious rats. Ottlecz A, McCann SM. Life Sci; 1988 Mar 05; 43(25):2077-85. PubMed ID: 3062293 [Abstract] [Full Text] [Related]
9. Central administration of antiserum to vasoactive intestinal peptide delays and reduces luteinizing hormone and prolactin surges in ovariectomized, estrogen-treated rats. van der Beek EM, Swarts HJ, Wiegant VM. Neuroendocrinology; 1999 Apr 05; 69(4):227-37. PubMed ID: 10207274 [Abstract] [Full Text] [Related]
10. Vasoactive intestinal peptide inhibits the steroid-induced LH surge in the ovariectomized rat. Weick RF, Stobie KM. J Endocrinol; 1992 Jun 05; 133(3):433-7. PubMed ID: 1613444 [Abstract] [Full Text] [Related]
11. Interleukin 1 alpha inhibits prostaglandin E2 release to suppress pulsatile release of luteinizing hormone but not follicle-stimulating hormone. Rettori V, Gimeno MF, Karara A, Gonzalez MC, McCann SM. Proc Natl Acad Sci U S A; 1991 Apr 01; 88(7):2763-7. PubMed ID: 1901415 [Abstract] [Full Text] [Related]
12. Oxytocin mediates the hypothalamic action of vasoactive intestinal peptide to stimulate prolactin secretion. Samson WK, Bianchi R, Mogg RJ, Rivier J, Vale W, Melin P. Endocrinology; 1989 Feb 01; 124(2):812-9. PubMed ID: 2912703 [Abstract] [Full Text] [Related]
13. Ovarian steroid modulation of norepinephrine action on luteinizing hormone release. Analogous effects in male and female rats. Condon TP, Handa RJ, Gorski RA, Sawyer CH, Whitmoyer DI. Neuroendocrinology; 1986 Feb 01; 43(5):550-6. PubMed ID: 3748310 [Abstract] [Full Text] [Related]
14. Norepinephrine inhibition of pulsatile LH release: receptor specificity. Bergen H, Leung PC. Am J Physiol; 1986 Feb 01; 250(2 Pt 1):E205-11. PubMed ID: 3953791 [Abstract] [Full Text] [Related]
15. Vasoactive intestinal peptide modulates luteinizing hormone subunit gene expression in the anterior pituitary in female rat. Gajewska A, Wolińska-Witort E, Kochman K. Brain Res Bull; 2005 Oct 30; 67(4):319-26. PubMed ID: 16182940 [Abstract] [Full Text] [Related]
16. On the relationship between noradrenergic stimulatory and GABAergic inhibitory systems in the control of luteinizing hormone secretion in female rats. Akema T, Chiba A, Kimura F. Neuroendocrinology; 1990 Dec 30; 52(6):566-72. PubMed ID: 2178232 [Abstract] [Full Text] [Related]
17. Third-ventricular infusion of neuropeptide Y suppresses luteinizing hormone secretion in ovariectomized rhesus macaques. Kaynard AH, Pau KY, Hess DL, Spies HG. Endocrinology; 1990 Nov 30; 127(5):2437-44. PubMed ID: 2226326 [Abstract] [Full Text] [Related]
18. Role of nitric oxide in the control of luteinizing hormone-releasing hormone release in vivo and in vitro. Rettori V, Belova N, Dees WL, Nyberg CL, Gimeno M, McCann SM. Proc Natl Acad Sci U S A; 1993 Nov 01; 90(21):10130-4. PubMed ID: 7694282 [Abstract] [Full Text] [Related]
19. Preoptic injection of VIP, but not of secretin or PHI, inhibits LH and stimulates prolactin secretion in the ovariectomized rat. Akema T, Hashimoto R, Kimura F. Brain Res; 1988 Feb 16; 441(1-2):367-70. PubMed ID: 3359239 [Abstract] [Full Text] [Related]
20. Effect of corticotropin-releasing hormone antagonist on oestrogen-dependent glucoprivic suppression of luteinizing hormone secretion in female rats. Tsukahara S, Tsukamura H, Foster DL, Maeda KI. J Neuroendocrinol; 1999 Feb 16; 11(2):101-5. PubMed ID: 10048464 [Abstract] [Full Text] [Related] Page: [Next] [New Search]